Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study

被引：0
|
作者：
Pozzilli, C. [1 ]
Phillips, J. T. [2 ]
Fox, R. J. [3 ]
Selmaj, K. [4 ]
Zhang, R. [5 ]
Novas, M. [5 ]
Sweetser, M. T. [5 ]
Gold, R. [6 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Med Univ Lodz, Lodz, Poland
[5] Biogen Idec Inc, Cambridge, MA USA
[6] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P066
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [11] Five-year follow-up of delayed-release dimethyl fumarate in RRMS: integrated clinical efficacy data from the DEFINE, CONFIRM, and ENDORSE Studies
    Hutchinson, M.
    Gold, R.
    Fox, R. J.
    Phillips, J. T.
    Bar-Or, A.
    Kappos, L.
    Sheikh, S.
    Zhang, R.
    Yang, M.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 153 - 153
  • [12] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated MRI outcomes from DEFINE, CONFIRM, and the ENDORSE extension study
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D. G.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Miller, D. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 130 - 130
  • [13] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated MRI outcomes from DEFINE, CONFIRM, and the ENDORSE extension study
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D. G.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Miller, D. H.
    JOURNAL OF NEUROLOGY, 2014, 261 : S93 - S93
  • [14] Long-term follow-up of the effect of delayed-release dimethyl fumarate on No Evidence of Disease Activity in patients with multiple sclerosis
    Giovannoni, G.
    Havrdova, E.
    Gold, R.
    Fox, R. J.
    Kappos, L.
    Phillips, J. T.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 479 - 479
  • [15] Long-term follow-up of the effect of delayed-release dimethyl fumarate on no evident disease activity in patients with multiple sclerosis
    Giovannoni, G.
    Gold, R.
    Fox, R. J.
    Kappos, L.
    Phillips, T.
    Zhang, A.
    Kurukulasuriya, N. C.
    Havrdova, E.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 44 - 45
  • [16] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated clinical efficacy data from DEFINE, CONFIRM, and the ENDORSE extension study
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 344 - 344
  • [17] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated clinical efficacy data from DEFINE, CONFIRM, and the ENDORSE extension study
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S233 - S233
  • [18] Safety of Delayed-release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis Patients from ENDORSE: Seven-Year Interim Results
    Pozzilli, Carlo
    Phillips, J. Theodore
    Fox, Robert J.
    Prada, Claudia
    Yang, Lili
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [19] Safety profile of BG-12 (dimethyl fumarate) in relapsing remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 457 - 457
  • [20] Long-term safety and efficacy of delayed-release dimethyl fumarate in paediatric patients with relapsing-remitting multiple sclerosis: a long-term extension of the FOCUS study
    Alroughani, R.
    Huppke, P.
    Pultz, J.
    Parks, B.
    Beynon, V.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 147 - 148
12345